| Group one (n = 33) | Group two (n = 17) |
---|---|---|
Age, years | 39.2 (10.0) | 35.8 (8.2) |
Female participants | 19 (57.6) | 11 (64.0) |
BMI, kg/m2 | 24.1 (4.2) | 24.1 (2.8) |
Participants receiving second vaccine dose | 13 (77) | 17 (100) |
Participants receiving third vaccine dose | 4 (23) | 0 (0) |
Participants with CBT > 38.0 °C | 23 (69.0) | 11 (64) |
Monitoring duration, hours | 26.6 (8.4) | 26.1 (9.4) |